nodes	percent_of_prediction	percent_of_DWPC	metapath
Benzphetamine—ADRA1A—Endothelin Pathways—ADCY10—nephrolithiasis	0.0467	0.0511	CbGpPWpGaD
Benzphetamine—SLC18A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A12—nephrolithiasis	0.0296	0.0324	CbGpPWpGaD
Benzphetamine—Tropicamide—CHRM3—nephrolithiasis	0.0284	0.327	CrCbGaD
Benzphetamine—SLC18A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A9—nephrolithiasis	0.0275	0.0302	CbGpPWpGaD
Benzphetamine—Isopropamide—CHRM3—nephrolithiasis	0.0232	0.267	CrCbGaD
Benzphetamine—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A12—nephrolithiasis	0.0199	0.0218	CbGpPWpGaD
Benzphetamine—SLC18A2—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.0194	0.0213	CbGpPWpGaD
Benzphetamine—ADRA1A—Monoamine GPCRs—CHRM3—nephrolithiasis	0.0194	0.0212	CbGpPWpGaD
Benzphetamine—Diphenidol—CHRM3—nephrolithiasis	0.0192	0.221	CrCbGaD
Benzphetamine—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A9—nephrolithiasis	0.0185	0.0203	CbGpPWpGaD
Benzphetamine—ADRA2A—Monoamine GPCRs—CHRM3—nephrolithiasis	0.018	0.0197	CbGpPWpGaD
Benzphetamine—SLC18A2—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.0178	0.0194	CbGpPWpGaD
Benzphetamine—SLC18A2—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.0178	0.0194	CbGpPWpGaD
Benzphetamine—SLC6A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A12—nephrolithiasis	0.0177	0.0193	CbGpPWpGaD
Benzphetamine—SLC6A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A9—nephrolithiasis	0.0164	0.018	CbGpPWpGaD
Benzphetamine—ADRA1A—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.0163	0.0178	CbGpPWpGaD
Benzphetamine—ADRA2A—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.0151	0.0166	CbGpPWpGaD
Benzphetamine—SLC18A2—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.0135	0.0147	CbGpPWpGaD
Benzphetamine—SLC18A2—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.0135	0.0147	CbGpPWpGaD
Benzphetamine—SLC6A2—NRF2 pathway—SLC2A9—nephrolithiasis	0.0134	0.0146	CbGpPWpGaD
Benzphetamine—SLC6A2—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.0131	0.0143	CbGpPWpGaD
Benzphetamine—SLC18A2—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.0125	0.0137	CbGpPWpGaD
Benzphetamine—SLC18A2—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.0125	0.0137	CbGpPWpGaD
Benzphetamine—SLC6A2—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.0119	0.0131	CbGpPWpGaD
Benzphetamine—SLC6A2—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.0119	0.0131	CbGpPWpGaD
Benzphetamine—ADRA1A—Calcium Regulation in the Cardiac Cell—RGS14—nephrolithiasis	0.0119	0.013	CbGpPWpGaD
Benzphetamine—SLC6A3—NRF2 pathway—SLC2A9—nephrolithiasis	0.0118	0.013	CbGpPWpGaD
Benzphetamine—SLC6A3—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.0116	0.0127	CbGpPWpGaD
Benzphetamine—SLC18A2—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.0112	0.0122	CbGpPWpGaD
Benzphetamine—SLC18A2—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.0111	0.0121	CbGpPWpGaD
Benzphetamine—SLC18A2—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.0111	0.0121	CbGpPWpGaD
Benzphetamine—SLC6A3—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.0106	0.0116	CbGpPWpGaD
Benzphetamine—SLC6A3—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.0106	0.0116	CbGpPWpGaD
Benzphetamine—SLC18A2—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00987	0.0108	CbGpPWpGaD
Benzphetamine—ADRA2A—Regulation of insulin secretion—CHRM3—nephrolithiasis	0.00915	0.01	CbGpPWpGaD
Benzphetamine—SLC6A2—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.00906	0.00992	CbGpPWpGaD
Benzphetamine—SLC6A2—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.00906	0.00992	CbGpPWpGaD
Benzphetamine—SLC18A2—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00902	0.00988	CbGpPWpGaD
Benzphetamine—SLC18A2—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00902	0.00988	CbGpPWpGaD
Benzphetamine—Promethazine—CHRM3—nephrolithiasis	0.00852	0.0982	CrCbGaD
Benzphetamine—SLC6A2—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.00842	0.00922	CbGpPWpGaD
Benzphetamine—SLC6A2—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.00842	0.00922	CbGpPWpGaD
Benzphetamine—SLC6A3—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.00802	0.00878	CbGpPWpGaD
Benzphetamine—SLC6A3—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.00802	0.00878	CbGpPWpGaD
Benzphetamine—ADRA2A—G alpha (i) signalling events—RGS14—nephrolithiasis	0.00767	0.0084	CbGpPWpGaD
Benzphetamine—SLC6A2—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.0075	0.00822	CbGpPWpGaD
Benzphetamine—Promazine—CHRM3—nephrolithiasis	0.0075	0.0864	CrCbGaD
Benzphetamine—SLC6A3—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.00746	0.00817	CbGpPWpGaD
Benzphetamine—SLC6A3—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.00746	0.00817	CbGpPWpGaD
Benzphetamine—SLC6A2—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00745	0.00816	CbGpPWpGaD
Benzphetamine—SLC6A2—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00745	0.00816	CbGpPWpGaD
Benzphetamine—ADRA2A—Integration of energy metabolism—CHRM3—nephrolithiasis	0.00719	0.00787	CbGpPWpGaD
Benzphetamine—CYP2B6—Biological oxidations—SLC26A1—nephrolithiasis	0.007	0.00766	CbGpPWpGaD
Benzphetamine—SLC18A2—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00684	0.00749	CbGpPWpGaD
Benzphetamine—SLC18A2—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00684	0.00749	CbGpPWpGaD
Benzphetamine—ADRA1A—G alpha (q) signalling events—DGKH—nephrolithiasis	0.00669	0.00733	CbGpPWpGaD
Benzphetamine—SLC6A3—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.00665	0.00728	CbGpPWpGaD
Benzphetamine—SLC6A2—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00664	0.00727	CbGpPWpGaD
Benzphetamine—SLC6A3—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.0066	0.00723	CbGpPWpGaD
Benzphetamine—SLC6A3—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.0066	0.00723	CbGpPWpGaD
Benzphetamine—SLC18A2—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.00636	0.00696	CbGpPWpGaD
Benzphetamine—SLC18A2—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.00636	0.00696	CbGpPWpGaD
Benzphetamine—SLC6A2—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00607	0.00665	CbGpPWpGaD
Benzphetamine—SLC6A2—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00607	0.00665	CbGpPWpGaD
Benzphetamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—DGKH—nephrolithiasis	0.00599	0.00656	CbGpPWpGaD
Benzphetamine—SLC6A3—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00588	0.00644	CbGpPWpGaD
Benzphetamine—ADRA1A—Calcium Regulation in the Cardiac Cell—CHRM3—nephrolithiasis	0.0058	0.00636	CbGpPWpGaD
Benzphetamine—SLC18A2—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00567	0.00621	CbGpPWpGaD
Benzphetamine—SLC18A2—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00567	0.00621	CbGpPWpGaD
Benzphetamine—ADRA2A—Platelet activation, signaling and aggregation—DGKH—nephrolithiasis	0.00544	0.00596	CbGpPWpGaD
Benzphetamine—SLC6A3—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00538	0.00589	CbGpPWpGaD
Benzphetamine—SLC6A3—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00538	0.00589	CbGpPWpGaD
Benzphetamine—ADRA1A—G alpha (q) signalling events—CHRM3—nephrolithiasis	0.00484	0.0053	CbGpPWpGaD
Benzphetamine—SLC6A2—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.0046	0.00504	CbGpPWpGaD
Benzphetamine—SLC6A2—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.0046	0.00504	CbGpPWpGaD
Benzphetamine—SLC18A2—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.00453	0.00496	CbGpPWpGaD
Benzphetamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—CHRM3—nephrolithiasis	0.00433	0.00474	CbGpPWpGaD
Benzphetamine—SLC6A2—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.00428	0.00468	CbGpPWpGaD
Benzphetamine—SLC6A2—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.00428	0.00468	CbGpPWpGaD
Benzphetamine—SLC6A3—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00408	0.00446	CbGpPWpGaD
Benzphetamine—SLC6A3—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00408	0.00446	CbGpPWpGaD
Benzphetamine—SLC6A2—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00381	0.00418	CbGpPWpGaD
Benzphetamine—SLC6A2—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00381	0.00418	CbGpPWpGaD
Benzphetamine—SLC6A3—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.00379	0.00415	CbGpPWpGaD
Benzphetamine—SLC6A3—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.00379	0.00415	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00374	0.0041	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00348	0.00381	CbGpPWpGaD
Benzphetamine—SLC6A3—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00338	0.0037	CbGpPWpGaD
Benzphetamine—SLC6A3—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00338	0.0037	CbGpPWpGaD
Benzphetamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00321	0.00351	CbGpPWpGaD
Benzphetamine—CYP3A4—Biological oxidations—SLC26A1—nephrolithiasis	0.00318	0.00348	CbGpPWpGaD
Benzphetamine—SLC6A2—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.00305	0.00334	CbGpPWpGaD
Benzphetamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00298	0.00326	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR downstream signaling—RGS14—nephrolithiasis	0.00282	0.00309	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—SLC7A9—nephrolithiasis	0.00281	0.00307	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—DGKH—nephrolithiasis	0.00281	0.00307	CbGpPWpGaD
Benzphetamine—SLC6A3—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.0027	0.00296	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR downstream signaling—RGS14—nephrolithiasis	0.00262	0.00287	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—RGS14—nephrolithiasis	0.00256	0.00281	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR ligand binding—CHRM3—nephrolithiasis	0.00244	0.00267	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—RGS14—nephrolithiasis	0.00238	0.00261	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR ligand binding—CHRM3—nephrolithiasis	0.00227	0.00248	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR ligand binding—PTH—nephrolithiasis	0.00223	0.00244	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR ligand binding—PTH—nephrolithiasis	0.00207	0.00227	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR downstream signaling—DGKH—nephrolithiasis	0.00191	0.00209	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—ADCY10—nephrolithiasis	0.00178	0.00195	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR downstream signaling—DGKH—nephrolithiasis	0.00177	0.00194	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—DGKH—nephrolithiasis	0.00173	0.0019	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—GRHPR—nephrolithiasis	0.00168	0.00184	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—ADCY10—nephrolithiasis	0.00166	0.00181	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—DGKH—nephrolithiasis	0.00161	0.00176	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—GRHPR—nephrolithiasis	0.00158	0.00173	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—RGS14—nephrolithiasis	0.00152	0.00166	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—AGXT—nephrolithiasis	0.0015	0.00164	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—RGS14—nephrolithiasis	0.00141	0.00154	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—AGXT—nephrolithiasis	0.00141	0.00154	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR downstream signaling—CHRM3—nephrolithiasis	0.00138	0.00151	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR downstream signaling—CHRM3—nephrolithiasis	0.00128	0.0014	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—SLC26A1—nephrolithiasis	0.00128	0.0014	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—APRT—nephrolithiasis	0.00128	0.0014	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR downstream signaling—PTH—nephrolithiasis	0.00126	0.00138	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—CHRM3—nephrolithiasis	0.00125	0.00137	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—SLC26A1—nephrolithiasis	0.0012	0.00131	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—APRT—nephrolithiasis	0.0012	0.00131	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR downstream signaling—PTH—nephrolithiasis	0.00117	0.00128	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—CHRM3—nephrolithiasis	0.00116	0.00127	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—PTH—nephrolithiasis	0.00115	0.00125	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—PTH—nephrolithiasis	0.00106	0.00117	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.00102	0.00112	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—DGKH—nephrolithiasis	0.00102	0.00112	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000951	0.00104	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—DGKH—nephrolithiasis	0.000951	0.00104	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—AQP1—nephrolithiasis	0.000909	0.000996	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—AQP1—nephrolithiasis	0.000852	0.000933	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—CHRM3—nephrolithiasis	0.000822	0.0009	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—CHRM3—nephrolithiasis	0.000771	0.000844	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—CHRM3—nephrolithiasis	0.00074	0.00081	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—GRHPR—nephrolithiasis	0.000717	0.000785	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—CHRM3—nephrolithiasis	0.000688	0.000753	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—PTH—nephrolithiasis	0.000677	0.000741	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—AGXT—nephrolithiasis	0.000639	0.0007	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—PTH—nephrolithiasis	0.000629	0.000689	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—SLC26A1—nephrolithiasis	0.000544	0.000595	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—APRT—nephrolithiasis	0.000544	0.000595	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—AQP1—nephrolithiasis	0.000387	0.000424	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—CHRM3—nephrolithiasis	0.00035	0.000384	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—SPP1—nephrolithiasis	0.00034	0.000372	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—SPP1—nephrolithiasis	0.000316	0.000346	CbGpPWpGaD
